Advertisement

Cost-Effectiveness of Continuous Positive Airway Pressure Therapy Versus Other Treatments of Obstructive Sleep Apnea

Published:October 09, 2022DOI:https://doi.org/10.1016/j.jsmc.2022.07.003

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Sleep Medicine Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bradley T.D.
        • Floras J.S.
        Obstructive sleep apnoea and its cardiovascular consequences.
        Lancet. 2009; 373: 82-93
        • Dempsey J.A.
        • Veasey S.C.
        • Morgan B.J.
        • et al.
        Pathophysiology of sleep apnea.
        Physiol Rev. 2010; 90: 47-112
        • Veasey S.C.
        • Rosen I.M.
        Obstructive sleep apnea in adults.
        N Engl J Med. 2019; 380: 1442-1449
        • McEvoy R.D.
        • Antic N.A.
        • Heeley E.
        • et al.
        CPAP for prevention of cardiovascular events in obstructive sleep apnea.
        N Engl J Med. 2016; 375: 919-931
        • Mokhlesi B.
        • Ayas N.T.
        Cardiovascular events in obstructive sleep apnea - can CPAP therapy SAVE lives?.
        N Engl J Med. 2016; 375: 994-996
        • Epstein L.J.
        • Kristo D.
        • Strollo P.J.
        • et al.
        Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults.
        J Clin Sleep Med. 2009; 5: 263-276
        • Peppard P.E.
        • Young T.
        • Barnet J.H.
        • et al.
        Increased prevalence of sleep-disordered breathing in adults.
        Am J Epidemiol. 2013; 177: 1006-1014
        • Benjafield A.V.
        • Ayas N.T.
        • Eastwood P.R.
        • et al.
        Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis.
        Lancet Respir Med. 2019; 7: 687-698
      1. Frost & Sullivan. Hidden health crisis costing America billions. Underdiagnosing and undertreating obstructive sleep apnea draining healthcare system. 2016.

        • Streatfeild J.
        • Smith J.
        • Mansfield D.
        • et al.
        The social and economic cost of sleep disorders.
        Sleep. 2021; https://doi.org/10.1093/sleep/zsab132
        • Muennig P.
        • Bounthavong M.
        Cost-effectiveness analysis in health : a practical approach.
        John Wiley & Sons, Incorporated, San Francisco, CA2016
        • Cohen D.J.
        • Reynolds M.R.
        Interpreting the results of cost-effectiveness studies.
        J Am Coll Cardiol. 2008; 52: 2119-2126
        • Neumann P.J.
        • Cohen J.T.
        • Weinstein M.C.
        Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY threshold.
        N Engl J Med. 2014; 371: 796-797
        • Pachito D.V.
        • Â Bagattini
        • Drager L.F.
        • et al.
        Economic evaluation of CPAP therapy for obstructive sleep apnea: a scoping review and evidence map.
        Sleep Breath. 2021; https://doi.org/10.1007/s11325-021-02362-8
        • Guest J.F.
        • Panca M.
        • Sladkevicius E.
        • et al.
        Clinical outcomes and cost-effectiveness of continuous positive airway pressure to manage obstructive sleep apnea in patients with type 2 diabetes in the U.K.
        Diabetes Care. 2014; 37: 1263-1271
        • McDaid C.
        • Griffin S.
        • Weatherly H.
        • et al.
        Continuous positive airway pressure devices for the treatment of obstructive sleep apnoea-hypopnoea syndrome: a systematic review and economic analysis.
        Health Technol Assess. 2009; 13 (xi-xiv, 1-119, 143-274): iii-iv
        • McMillan A.
        • Bratton D.J.
        • Faria R.
        • et al.
        A multicentre randomised controlled trial and economic evaluation of continuous positive airway pressure for the treatment of obstructive sleep apnoea syndrome in older people: PREDICT.
        Health Technol Assess. 2015; 19: 1-188
        • Chilcott J.
        • Clayton E.
        • Chada N.
        • et al.
        Nasal continuous positive airways pressure in the management of sleep apnoea. Guidance note for purchasers.
        in: Research TIfHS Universities of Leicester, Notthingham, and Sheffield2000
        • Guest J.F.
        • Helter M.T.
        • Morga A.
        • et al.
        Cost-effectiveness of using continuous positive airway pressure in the treatment of severe obstructive sleep apnoea/hypopnoea syndrome in the UK.
        Thorax. 2008; 63: 860-865
        • Streatfeild J.
        • Hillman D.
        • Adams R.
        • et al.
        Cost-effectiveness of continuous positive airway pressure therapy for obstructive sleep apnea: health care system and societal perspectives.
        Sleep. 2019; 42https://doi.org/10.1093/sleep/zsz181
        • Tousignant P.
        • Cosio M.G.
        • Levy R.D.
        • et al.
        Quality adjusted life years added by treatment of obstructive sleep apnea.
        Sleep. 1994; 17: 52-60
        • Ayas N.T.
        • FitzGerald J.M.
        • Fleetham J.A.
        • et al.
        Cost-effectiveness of continuous positive airway pressure therapy for moderate to severe obstructive sleep apnea/hypopnea.
        Arch Intern Med. 2006; 166: 977-984
        • Tan M.C.
        • Ayas N.T.
        • Mulgrew A.
        • et al.
        Cost-effectiveness of continuous positive airway pressure therapy in patients with obstructive sleep apnea-hypopnea in British Columbia.
        Can Respir J. 2008; 15: 159-165
        • Sadatsafavi M.
        • Marra C.A.
        • Ayas N.T.
        • et al.
        Cost-effectiveness of oral appliances in the treatment of obstructive sleep apnoea-hypopnoea.
        Sleep Breath. 2009; 13: 241-252
        • Sharples L.
        • Glover M.
        • Clutterbuck-James A.
        • et al.
        Clinical effectiveness and cost-effectiveness results from the randomised controlled Trial of Oral Mandibular Advancement Devices for Obstructive sleep apnoea-hypopnoea (TOMADO) and long-term economic analysis of oral devices and continuous positive airway pressure.
        Health Technol Assess. 2014; 18: 1-296
        • Poullié A.I.
        • Cognet M.
        • Gauthier A.
        • et al.
        Cost-effectiveness of treatments for mild-to-moderate obstructive sleep apnea in France.
        Int J Technol Assess Health Care. 2016; 32: 37-45
        • de Vries G.E.
        • Hoekema A.
        • Vermeulen K.M.
        • et al.
        Clinical- and cost-effectiveness of a mandibular advancement device versus continuous positive airway pressure in moderate obstructive sleep apnea.
        J Clin Sleep Med. 2019; 15: 1477-1485
        • Aurora R.N.
        • Casey K.R.
        • Kristo D.
        • et al.
        Practice parameters for the surgical modifications of the upper airway for obstructive sleep apnea in adults.
        Sleep. 2010; 33: 1408-1413
        • Tan K.B.
        • Toh S.T.
        • Guilleminault C.
        • et al.
        A cost-effectiveness analysis of surgery for middle-aged men with severe obstructive sleep apnea intolerant of CPAP.
        J Clin Sleep Med. 2015; 11: 525-535
        • Camacho M.
        • Riaz M.
        • Capasso R.
        • et al.
        The effect of nasal surgery on continuous positive airway pressure device use and therapeutic treatment pressures: a systematic review and meta-analysis.
        Sleep. 2015; 38: 279-286
        • Kempfle J.S.
        • BuSaba N.Y.
        • Dobrowski J.M.
        • et al.
        A cost-effectiveness analysis of nasal surgery to increase continuous positive airway pressure adherence in sleep apnea patients with nasal obstruction.
        Laryngoscope. 2017; 127: 977-983
        • Strollo P.J.
        • Soose R.J.
        • Maurer J.T.
        • et al.
        Upper-airway stimulation for obstructive sleep apnea.
        N Engl J Med. 2014; 370: 139-149
        • Certal V.F.
        • Zaghi S.
        • Riaz M.
        • et al.
        Hypoglossal nerve stimulation in the treatment of obstructive sleep apnea: a systematic review and meta-analysis.
        Laryngoscope. 2015; 125: 1254-1264
      2. Available at: https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?LCDId=38385&ver=40&DocID=L38385&bc=gAAAAAgAAAAA&. Accessed October 1, 2021.

        • Pietzsch J.B.
        • Liu S.
        • Garner A.M.
        • et al.
        Long-term cost-effectiveness of upper airway stimulation for the treatment of obstructive sleep apnea: a model-based projection based on the STAR trial.
        Sleep. 2015; 38: 735-744
        • Pietzsch J.B.
        • Richter A.K.
        • Randerath W.
        • et al.
        Clinical and economic benefits of upper airway stimulation for obstructive sleep apnea in a European setting.
        Respiration. 2019; 98: 38-47
        • Blissett D.B.
        • Steier J.S.
        • Karagama Y.G.
        • et al.
        Breathing synchronised hypoglossal nerve stimulation with inspire for untreated severe obstructive sleep apnoea/hypopnoea syndrome: a simulated cost-utility analysis from a national health service perspective.
        Pharmacoecon Open. 2021; 5: 475-489
        • Collop N.
        • Stierer T.L.
        • Shafazand S.
        SAVE me from CPAP.
        J Clin Sleep Med. 2016; 12: 1701-1704